Jean Coutu Group PJC Inc (TSE:PJC.A)‘s stock had its “reduce” rating restated by investment analysts at TD Securities in a report issued on Thursday. They presently have a C$17.50 price objective on the stock.

A number of other brokerages have also recently commented on PJC.A. Scotiabank reaffirmed a “sector perform” rating and issued a C$19.00 target price on shares of Jean Coutu Group PJC in a report on Thursday. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a C$20.00 target price on shares of Jean Coutu Group PJC in a report on Thursday. Dundee Securities reaffirmed a “neutral” rating and issued a C$20.00 target price on shares of Jean Coutu Group PJC in a report on Thursday, September 22nd. Finally, CIBC reaffirmed a “sector perform” rating and issued a C$19.00 target price on shares of Jean Coutu Group PJC in a report on Wednesday, July 6th. One equities research analyst has rated the stock with a sell rating and six have issued a hold rating to the stock. The stock has an average rating of “Hold” and an average target price of C$19.31.

Analyst Recommendations for Jean Coutu Group PJC (TSE:PJC.A)

About Jean Coutu Group PJC

The Jean Coutu Group (PJC) Inc is a Canada-based company, which is engaged in franchising pharmacy chains. The Company operates through two segments: franchising and generic drugs. Within the franchising segment, the Company carries on the franchising activity under the banners of PJC Jean Coutu, PJC Clinique, PJC Jean Coutu Sante and PJC Jean Coutu Sante Beaute; operates approximately two distribution centers, and coordinates various other services for its franchisees.

Receive News & Stock Ratings for Jean Coutu Group PJC Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jean Coutu Group PJC Inc and related stocks with our FREE daily email newsletter.